Biohaven Ltd.
BHVN
$29.86
-$0.54-1.78%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -29.07% | -56.28% | -253.94% | -154.64% | 28.02% |
| Total Depreciation and Amortization | 29.94% | 29.65% | 6.72% | -12.31% | 450.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.44% | -201.19% | 6,182.28% | 2,366.72% | -70.96% |
| Change in Net Operating Assets | 31.00% | 637.76% | -156.35% | 336.90% | -772.57% |
| Cash from Operations | -48.63% | -49.00% | -277.98% | -32.20% | -52.35% |
| Capital Expenditure | 89.57% | 51.04% | -395.63% | 40.14% | -56.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,444.34% | -255.17% | -223.60% | 10,618.52% | 98.69% |
| Cash from Investing | -2,140.06% | -259.52% | -228.43% | 3,313.50% | 98.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.06% | -- | -- | 563.55% | -12.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -269.91% | 110.12% | 124.02% | -95.37% | -101.09% |
| Cash from Financing | 11.26% | 302.68% | 1,678.85% | -87.16% | -53.74% |
| Foreign Exchange rate Adjustments | 128.39% | 100.00% | 95.68% | -140.00% | -172.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.49% | -103.13% | 387.56% | -25.33% | -34.03% |
